Financial statements Apteki Cefarm
Balance sheet data of APTEKI CEFARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 48 857 703,95 | 50 983 983,73 | 57 455 764,59 | 64 820 408,53 | 69 109 010,71 | 70 278 025,02 |
| A. Fixed assets | 28 731 174,48 | 26 607 958,16 | 33 804 309,00 | 37 452 639,39 | 37 012 539,39 | 33 127 882,36 |
| B. Current assets | 20 126 529,47 | 24 376 025,57 | 23 651 455,59 | 27 367 769,14 | 32 096 471,32 | 37 150 142,66 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 48 857 703,95 | 50 983 983,73 | 57 455 764,59 | 64 820 408,53 | 69 109 010,71 | 70 278 025,02 |
| A. Equity | 34 073 462,09 | 32 457 309,48 | 41 107 689,72 | 46 201 336,28 | 49 241 111,73 | 48 062 501,94 |
| B. Liabilities and provisions for liabilities | 14 784 241,86 | 18 526 674,25 | 16 348 074,87 | 18 619 072,25 | 19 867 898,98 | 22 215 523,08 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 13 989 034,01 | 17 816 848,65 | 15 501 341,20 | 17 763 453,33 | 18 494 503,20 | 20 722 460,21 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.